Effects of Melatonin on Exercise-Induced Oxidative Stress in Adults with Obesity Undergoing a Multidisciplinary Body Weight Reduction Program
<b>Background:</b> Obesity is characterized by increased oxidative stress, which, in a vicious circle, promotes chronic low-grade inflammation. Melatonin, a well-documented antioxidant, might be useful as a supplement to enhance the cardiometabolic benefits of any body weight reduction program (BWRP). <b>Objectives/Methods:</b> The present study aimed to evaluate the post-exercise oxidative stress and inflammation in a group of subjects with obesity treated with melatonin (2 mg/die) or placebo, undergoing a 2-week BWRP, with the administration of a single bout of acute exercise at the start and the end of the protocol (G1-G15). <b>Results:</b> Eighteen adults with obesity were enrolled and distributed to the two arms of the study: the melatonin group (F/M: 7/2; age: 27.8 ± 5.6 years; body mass index [BMI]: 43.0 ± 4.9 kg/m<sup>2</sup>) and the placebo group (F/M: 6/3; age: 28.8 ± 5.0 years; BMI: 42.8 ± 4.0 kg/m<sup>2</sup>). BWRP induced a decrease in BMI and waist circumference (WC) in both groups; plasma glucose, blood glycated hemoglobin (HbA<sub>1c</sub>), and neutrophil to lymphocyte ratio (NLR) were reduced only in the placebo group. Importantly, plasma biological antioxidant potential (BAP) increased throughout BWRP. Paradoxically, melatonin enhanced post-exercise production of plasma derivatives of reactive oxygen metabolites (d-ROMs) and erythrocytic glutathionyl-Hb (HbSSG) (at G1 and G15). Finally, differently from the placebo group, melatonin-treated subjects did not exhibit the BWRP-induced decrease in plasma levels of interleukin-6 (IL-6), before and after exercise, at the end of two weeks (G15). <b>Conclusions:</b> Melatonin is presumably an antioxidant with "conditional" prooxidant actions. The use of melatonin as a supplement in subjects with obesity might be deleterious due to the abolishment of BWRP-induced cardiometabolic benefits.
Authors
- Stefania Mai (ORCID: https://orcid.org/0000-0002-1054-2677)
- Silvano Gabriele Cella (ORCID: https://orcid.org/0000-0001-6884-3766)
- Federico Maria Rubino (ORCID: https://orcid.org/0000-0001-9620-1883)
- Alessandro Sartório (ORCID: https://orcid.org/0000-0002-9620-4133)
- Antonello Emilio Rigamonti (ORCID: https://orcid.org/0000-0002-2489-9108)
- Adele Bondesan (ORCID: https://orcid.org/0000-0002-9145-5400)
- Rita Clara Paroni (ORCID: https://orcid.org/0000-0002-3186-8860)
- Diana Caroli (ORCID: https://orcid.org/0000-0002-0727-7470)
- Lucia Centofanti (ORCID: https://orcid.org/0009-0000-1301-9390)
Institutions
- University of Milan (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3390/jcm13175216
- Citations
- 7
- Primary Topic
- Circadian rhythm and melatonin
- Type
- article
- Field-Weighted Citation Impact
- 1.92
Funders
- European Commission
- Ministero della Salute
- Istituto Auxologico Italiano